| Item Type | Name |
|
Academic Article
|
Modeling deuterated glucose labeling of T-lymphocytes.
|
|
Academic Article
|
The HIV-1 vaccine race.
|
|
Academic Article
|
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes.
|
|
Academic Article
|
Determining the relative efficacy of highly active antiretroviral therapy.
|
|
Academic Article
|
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.
|
|
Academic Article
|
HIV-1 dynamics in vivo: implications for therapy.
|
|
Academic Article
|
HIV and lymphocyte dynamics.
|
|
Academic Article
|
In vivo replication kinetics of a nef-deleted strain of HIV-1.
|
|
Academic Article
|
Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification.
|
|
Academic Article
|
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4.
|
|
Academic Article
|
Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication.
|
|
Academic Article
|
The distribution of viral blips observed in HIV-1 infected patients treated with combination antiretroviral therapy.
|
|
Academic Article
|
Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide.
|
|
Academic Article
|
Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infection.
|
|
Academic Article
|
A recoding method to improve the humoral immune response to an HIV DNA vaccine.
|
|
Academic Article
|
Viral blip dynamics during highly active antiretroviral therapy.
|
|
Academic Article
|
A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding.
|
|
Academic Article
|
Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China.
|
|
Academic Article
|
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine.
|
|
Academic Article
|
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine.
|
|
Academic Article
|
Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy.
|
|
Academic Article
|
Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china.
|
|
Academic Article
|
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.
|
|
Academic Article
|
HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in mice.
|
|
Academic Article
|
Anti-CD4 monoclonal antibody ibalizumab exhibits breadth and potency against HIV-1, with natural resistance mediated by the loss of a V5 glycan in envelope.
|
|
Academic Article
|
Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication.
|
|
Academic Article
|
Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China.
|
|
Academic Article
|
HIV-1 at 25.
|
|
Academic Article
|
Design, construction, and characterization of a multigenic modified vaccinia Ankara candidate vaccine against human immunodeficiency virus type 1 subtype C/B'.
|
|
Academic Article
|
Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant.
|
|
Academic Article
|
Epitope mapping of ibalizumab, a humanized anti-CD4 monoclonal antibody with anti-HIV-1 activity in infected patients.
|
|
Academic Article
|
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation.
|
|
Academic Article
|
Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody.
|
|
Academic Article
|
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development.
|
|
Academic Article
|
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers.
|
|
Academic Article
|
Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC.
|
|
Academic Article
|
In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?
|
|
Academic Article
|
Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy.
|
|
Academic Article
|
Duration of an intermittent episode of viremia.
|
|
Academic Article
|
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.
|
|
Academic Article
|
The changing face of HIV in China.
|
|
Academic Article
|
CD40L-containing virus-like particle as a candidate HIV-1 vaccine targeting dendritic cells.
|
|
Academic Article
|
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.
|
|
Concept
|
HIV Antigens
|
|
Concept
|
HIV-1
|
|
Concept
|
HIV Fusion Inhibitors
|
|
Concept
|
HIV Integrase Inhibitors
|
|
Concept
|
HIV Envelope Protein gp160
|
|
Concept
|
HIV Antibodies
|
|
Concept
|
HIV Protease Inhibitors
|
|
Concept
|
HIV Envelope Protein gp120
|
|
Concept
|
HIV
|
|
Concept
|
HIV Core Protein p24
|
|
Concept
|
HIV Infections
|
|
Concept
|
Anti-HIV Agents
|
|
Academic Article
|
Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1.
|
|
Academic Article
|
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity.
|
|
Academic Article
|
Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.
|
|
Academic Article
|
Rational design and characterization of the novel, broad and potent bispecific HIV-1 neutralizing antibody iMabm36.
|
|
Academic Article
|
Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.
|
|
Academic Article
|
CRISPR-based gene knockout screens reveal deubiquitinases involved in HIV-1 latency in two Jurkat cell models.
|
|
Academic Article
|
The Miami Monkey: A Sunny Alternative to the Berlin Patient.
|
|
Academic Article
|
VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA.
|
|
Academic Article
|
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.
|
|
Academic Article
|
Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo.
|
|
Academic Article
|
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.
|
|
Academic Article
|
Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide.
|
|
Academic Article
|
Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.
|
|
Academic Article
|
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity.
|
|
Academic Article
|
V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.
|
|
Academic Article
|
The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8.
|
|
Academic Article
|
Engineering multi-specific antibodies against HIV-1.
|
|
Academic Article
|
Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific Antibodies.
|
|
Academic Article
|
Cabotegravir long acting injection protects macaques against intravenous challenge with SIVmac251.
|
|
Academic Article
|
DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers.
|